XML 66 R56.htm IDEA: XBRL DOCUMENT v3.23.3
Stockholders' Equity (Details) - USD ($)
$ / shares in Units, shares in Millions
1 Months Ended 3 Months Ended 9 Months Ended
Jan. 31, 2023
Aug. 31, 2021
Sep. 30, 2023
Mar. 31, 2023
Sep. 30, 2023
Sep. 30, 2022
Subsidiary, Sale of Stock [Line Items]            
Proceeds from issuance of common stock in at the market offering, net of issuance costs         $ 119,248,000 $ 52,845,000
Common stock            
Subsidiary, Sale of Stock [Line Items]            
Maximum aggregate offering price $ 250,000,000          
2021 Open Market Sales Agreement            
Subsidiary, Sale of Stock [Line Items]            
Commission on sale of stock per agreement (as percent)   3.00%        
Total of gross proceeds       $ 150,000,000    
Issuance of common stock in at the market offering (in shares)       15.5    
Proceeds from issuance of common stock in at the market offering, net of issuance costs       $ 51,900,000    
2021 Open Market Sales Agreement | Common stock            
Subsidiary, Sale of Stock [Line Items]            
Maximum aggregate offering price   $ 150,000,000        
2023 Open Market Sales Agreement            
Subsidiary, Sale of Stock [Line Items]            
Commission on sale of stock per agreement (as percent) 3.00%          
Issuance of common stock in at the market offering (in shares)     13.8   16.8  
Proceeds from issuance of common stock in at the market offering, net of issuance costs     $ 58,400,000   $ 70,000,000  
Weighted-average sales price per share (in dollars per share)     $ 4.24   $ 4.17  
2023 Open Market Sales Agreement | Common stock            
Subsidiary, Sale of Stock [Line Items]            
Maximum aggregate offering price $ 150,000,000